Legal & General Group PLC Vista Gen Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.14 - $4.8 $343 - $11,764
-2,451 Reduced 10.58%
20,708 $3,000
Q2 2022

Aug 22, 2022
BUY
$0.88 - $1.73 $3,087 - $6,070
3,509 Added 17.86%
23,159 $20,000
Q4 2021

Feb 14, 2022
BUY
$1.67 - $2.76 $352 - $582
211 Added 1.09%
19,650 $38,000
Q2 2021

Aug 12, 2021
BUY
$1.96 - $3.15 $38,100 - $61,232
19,439 New
19,439 $61,000

Others Institutions Holding VTGN

# of Institutions
2
Shares Held
2.7M
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $610M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email